Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper-Reference-Cited by-同舟云学术

Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper

Published:2021-02 Issue: Volume:158 Page:103203
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Busca Alessandro,Cattaneo Chiara,De Carolis Elena,Nadali Gianpaolo,Offidani Massimo,Picardi Marco,Candoni Anna,Ceresoli Eleonora,Criscuolo Marianna,Delia Mario,Della Pepa Roberta,Del Principe Ilaria,Fanci Roma. Rosa,Farina Francesca,Fracchiolla Nicola,Giordano Claudia,Malagola Michele,Marchesi Francesco,Piedimonte Monica,Prezioso Lucia,Quinto Angela Maria,Spolzino Angelica,Tisi Maria Chiara,Trastulli Fabio,Trecarichi Enrico Maria,Zappasodi Patrizia,Tumbarello Mario,Pagano Livio

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference148 articles.

1. Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib;Ahn;Blood.,2016

2. Children’s oncology group. Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial;Alexander;JAMA,2018

3. Lenalidomide, Bortezomib, and dexamethasone with transplantation for myeloma;Attal;N. Engl. J. Med.,2017

4. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients;Blimark;Haematologica.,2015

5. Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications;Blombery;Ann. Hematol.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we optimize antifungal use and stewardship in the treatment of acute leukemia?;Expert Review of Hematology;2024-07-25

2. Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies;Internal Medicine Journal;2023-12-08

3. Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections;Expert Review of Hematology;2023-04-03

4. Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology;Critical Reviews in Oncology/Hematology;2023-01

5. Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature;Frontiers in Oncology;2022-07-18